Detail
| LncRNA Name | LINC00514 |
| Synonyms | NA |
| Region | GRCh38_16:2988961-2994509 Sequence |
| Ensembl | ENSG00000262152 |
| RefSeq | NR_033861 |
| Circulating | ✘ |
| Drug-resisitant | ✘ |
| Prognostic | ✔ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | neuroendocrine prostate cancer |
| ICD-0-3 | |
| Methods | RNA-seq, Microarray, qPCR etc. |
| Sample | neuroendocrine prostate cancer tissues |
| Expression Pattern | up-regulated |
| Function Description | Top candidate lncRNAs FENDRR, H19, LINC00514, LINC00617, and SSTR5-AS3 identified in this study are implicated in the development of NEPC. |
| Pubmed ID | 29757368 |
| Year | 2018 |
| Title | The long noncoding RNA landscape of neuroendocrine prostate cancer and its clinical implications. |
| External Links |
| Links for LINC00514 | GenBank HGNC lncrnadb Noncode |
| Links for neuroendocrine prostate cancer | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.